[4th International Symposium. "Cerebrolysin: pharmacological effects and role in clinical practice"].
Gomazkov
O A
OA
D000293:Adolescent; D000368:Aged; D000596:Amino Acids / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003072:Cognition Disorders / Q000188:drug therapy; D015140:Dementia, Vascular / Q000188:drug therapy; D006556:Heroin Dependence / Q000188:drug therapy; D006801:Humans; D007223:Infant; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D009422:Nervous System Diseases / Q000188:drug therapy*; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D018697:Nootropic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D009896:Optic Atrophy / Q000188:drug therapy; D013313:Stress Disorders, Post-Traumatic / Q000188:drug therapy; D020521:Stroke / Q000188:drug therapy; D013997:Time Factors
D000596:Amino Acids; D018696:Neuroprotective Agents; D018697:Nootropic Agents; C006952:cerebrolysin